CompoAtlas

POSTMENOX

Food supplement declared in France, declaration No 2023-1-1075

POSTMENOX is a food supplement declared in France. Status: retiré du marché le 1 May 2024. 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
NURIBIOL
Status
Retiré du marché le 1 May 2024
Form
Gélule
Daily dose
2 gélules par jour
Directions for use
deux gélules par jour avec un verre d'eau
Intended populations
Femme
Not recommended for (according to the manufacturer)
Antécédent de cancer du sein, Femmes enceintes, Problèmes de foie, Sous antidépresseurs
Objectives stated by the manufacturer (these are not authorised claims)
Ménopause

Declaration 191402, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Trifolium pratense L.Parties aériennesExtrait sec hydroalcoolique400 mg
Salvia officinalis L.FeuilleExtrait sec aqueux306.76 mg
Padina pavonica (L.) ThivyThalleAutre extrait sec40 mg
Crocus sativus L.StigmatesAutre extrait sec30 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Chlorhydrate de pyridoxineVitamine B612 mg2 mg
Bisglycinate de zincZinc25 mg15 mg

Additives

E1204

Other ingredients

huile de tournesol

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Déconseillé aux personnes souffrant du foie ; demandez l’avis d’un professionnel de santé.L’usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein est déconseillé.L’emploi chez les femmes enceintes et les personnes sous antidépresseur est déconseillé.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Enter to analyse, Shift+Enter for a new line